Page 22 - GPD-4-3

Gene & Protein in Disease Targeting cathepsins during cancer development

54. Zhang H, Zhang L, Wei L, et al. Knockdown of cathepsin L Biophys Acta. 2003;1649(1):30-39.
sensitizes ovarian cancer cells to chemotherapy. Oncol Lett. doi: 10.1016/s1570-9639(03)00152-3
2016;11(6):4235-4239.
66. Hira VV, Verbovsek U, Breznik B, et al. Cathepsin K cleavage
doi: 10.3892/ol.2016.4494 of SDF-1alpha inhibits its chemotactic activity towards
55. Han ML, Zhao YF, Tan CH, et al. Cathepsin L upregulation- glioblastoma stem-like cells. Biochim Biophys Acta Mol Cell
induced EMT phenotype is associated with the acquisition Res. 2017;1864(3):594-603.
of cisplatin or paclitaxel resistance in A549 cells. Acta doi: 10.1016/j.bbamcr.2016.12.021
Pharmacol Sin. 2016;37(12):1606-1622.
67. Robotic B, Vizovisek M, Vidmar R, et al. Proteomic
doi: 10.1038/aps.2016.93
identification of cysteine cathepsin substrates shed from
56. Reiser J, Adair B, Reinheckel T. Specialized roles for the surface of cancer cells. Mol Cell Proteomics. 2015;4(8):
cysteine cathepsins in health and disease. J Clin Invest. 2213-2228.
2010;120(10):3421-3431. doi: 10.1074/mcp.M114.044628
doi: 10.1172/JCI42918
68. Clark AK, Yip PK, Malcangio M. The liberation of
57. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. fractalkine in the dorsal horn requires microglial cathepsin
Expression of the elastolytic cathepsins S and K in human S. J Neurosci. 2009;29(21):6945-6954.
atheroma and regulation of their production in smooth doi: 10.1523/JNEUROSCI.0828-09.2009
muscle cells. J Clin Invest. 1998;102(3):576-583.
69. Mohamed MM, Sloane BF. Cysteine cathepsins:
doi: 10.1172/JCI181 Multifunctional enzymes in cancer. Nat Rev Cancer.
58. Godat E, Herve-Grvepinet V, Veillard F, et al. Regulation 2006;6(10):764-775.
of cathepsin K activity by hydrogen peroxide. Biol Chem. doi: 10.1038/nrc1949
2008;389(8):1123-1126.
70. Caglic D, Pungercar JR, Pejler G, Turk V, Turk B.
doi: 10.1515/BC.2008.109
Glycosaminoglycans facilitate procathepsin B activation
59. Vizovisek M, Fonovic M, Turk B. Cysteine cathepsins through disruption of propeptide-mature enzyme
in extracellular matrix remodeling: Extracellular matrix interactions. J Biol Chem. 2007;282(45):33076-33085.
degradation and beyond. Matrix Biol. 2019;75-76:141-159. doi: 10.1074/jbc.M705761200
doi: 10.1016/j.matbio.2018.01.024 71. Ruettger A, Schueler S, Mollenhauer JA, Wiederanders B.
60. Gocheva V, Joyce JA. Cysteine cathepsins and the cutting Cathepsins B, K, and L are regulated by a defined collagen
edge of cancer invasion. Cell Cycle. 2007;6(1):60-64. type II peptide via activation of classical protein kinase C
and p38 MAP kinase in articular chondrocytes. J Biol Chem.
doi: 10.4161/cc.6.1.3669
2008;283(2):1043-1051.
61. Fonovic M, Turk B. Cysteine cathepsins and doi: 10.1074/jbc.M704915200
extracellular matrix degradation. Biochim Biophys Acta.
2014;1840(8):2560-25670. 72. Rampino N, Yamamoto H, Ionov Y, et al. Somatic
frameshift mutations in the BAX gene in colon cancers
doi: 10.1016/j.bbagen.2014.03.017
of the microsatellite mutator phenotype. Science.
62. Li Z, Yasuda Y, Li W, et al. Regulation of collagenase activities 1997;275(5302):967-969.
of human cathepsins by glycosaminoglycans. J Biol Chem. doi: 10.1126/science.275.5302.967
2004;279(7):5470-5479.
73. Zhang M, Zheng J, Nussinov R, Ma B. Oncogenic mutations
doi: 10.1074/jbc.M310349200
differentially affect bax monomer, dimer, and oligomeric
63. Repnik U, Starr AE, Overall CM, Turk B. Cysteine pore formation in the membrane. Sci Rep. 2016;6:33340.
cathepsins activate ELR chemokines and inactivate Non- doi: 10.1038/srep33340
ELR chemokines. J Biol Chem. 2015;290(22):13800-13811.
74. Zhang Z, Zhu W, Lapolla SM, et al. Bax forms an oligomer
doi: 10.1074/jbc.M115.638395
via separate, yet interdependent, surfaces. J Biol Chem.
64. Breznik B, Motaln H, Lah Turnsek T. Proteases and 2010;285(23):17614-17627.
cytokines as mediators of interactions between cancer and doi: 10.1074/jbc.M110.113456
stromal cells in tumours. Biol Chem. 2017;98(7):709-719.
75. Shibata MA, Liu ML, Knudson MC, et al. Haploid loss of
doi: 10.1515/hsz-2016-0283
bax leads to accelerated mammary tumor development in
65. Ohashi K, Naruto M, Nakaki T, Sano E. Identification of C3(1)/SV40-TAg transgenic mice: Reduction in protective
interleukin-8 converting enzyme as cathepsin L. Biochim apoptotic response at the preneoplastic stage. EMBO J.

Volume 4 Issue 3 (2025) 11 doi: 10.36922/gpd.4768